All In Biotech

Drug Trial Radar · NCT07761013

Yanlishuang Buccal Dropping Pills for Acute Pharyngitis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of Miao Medicine Yanlishuang Buccal Dropping Pills in Adults With Acute Pharyngitis

Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Mar 26, 2027

Study completion Jun 29, 2027

Sponsor

Lead sponsor
Beijing University of Chinese MedicineAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 12, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Acute pharyngitis commonly causes sore throat and pain on swallowing. This multicenter trial will compare Yanlishuang Buccal Dropping Pills with a matching placebo in 400 adults aged 18 to 65 years whose acute pharyngitis began within 48 hours and whose baseline throat-pain visual analog scale score is at least 4. Participants will be randomized 1:1 and treated under double-blind conditions. Each group will use four buccal dropping pills 4 to 6 times daily at intervals of at least 2 hours for up to 5 days. Participants whose sore throat resolves after at least 72 hours and remains absent for at least 24 hours may stop treatment early. The primary outcome is time to complete sore throat resolution. Secondary outcomes assess immediate pain relief, onset and resolution of pain, symptom and physical-sign response, complications, and work absence. Safety will be assessed using physical examinations, vital signs, laboratory tests, electrocardiograms, and adverse events.

Conditions

  • Acute Pharyngitis

Interventions

  • Yanlishuang Buccal Dropping PillsDrug

    Miao medicine buccal dropping pills supplied by the sponsor. The protocol lists Aipian/natural borneol, Blumea balsamifera oil, peppermint oil, menthol, and monoammonium glycyrrhizinate, with polyethylene glycol 6000 as excipient. Dose: 4 pills buccally per administration, 4 to 6 administrations per day, at intervals of at least 2 hours, for up to 5 days.

  • Yanlishuang Buccal Dropping Pills PlaceboDrug

    Matching placebo with identical dosage form, weight, packaging, schedule, and administration: 4 pills buccally per administration, 4 to 6 administrations per day, at intervals of at least 2 hours, for up to 5 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to complete sore throat resolutionTime frame: From the first dose until complete sore throat resolution, assessed up to Day 6.

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • First Affiliated Hospital of Guangzhou University of Chinese Medicine

    Guangzhou, Guangdong, China

  • Affiliated Hospital of Guizhou Medical University

    Guiyang, Guizhou, China

  • First Affiliated Hospital of Heilongjiang University of Chinese Medicine

    Harbin, Heilongjiang, China

  • Jiangsu Province Hospital of Chinese Medicine

    Nanjing, Jiangsu, China

  • Jiangxi Provincial Hospital of Traditional Chinese Medicine

    Nanchang, Jiangxi, China

  • First Affiliated Hospital of Shandong University of Traditional Chinese Medicine / Shandong Provincial Hospital of Traditional Chinese Medicine

    Jinan, Shandong, China

  • Shanghai Municipal Hospital of Traditional Chinese Medicine

    Shanghai, Shanghai Municipality, China

  • Affiliated Hospital of Chengdu University of Traditional Chinese Medicine / Sichuan Provincial Hospital of Traditional Chinese Medicine

    Chengdu, Sichuan, China

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

    Tianjin, Tianjin Municipality, China

  • First Affiliated Hospital of Yunnan University of Chinese Medicine / Yunnan Provincial Hospital of Traditional Chinese Medicine

    Kunming, Yunnan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.